Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharma Industry Applauds Final Push For Ratification Of Korea-U.S. FTA, Patent Linkage, Transparency, Among Benefits

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korean Prime Minister Kim Hwang-sik called on cabinet ministers to ratify Korea's free trade agreement with the United States during the country's National Assembly session Oct. 4

You may also be interested in...

Hanmi Third Pharma To Sell Generic Viagra In Korea

Korean companies are lining up to launch Viagra generics even though Pfizer Inc. claims its patent is enforceable until 2014.

Korea-U.S. FTA Takes Effect March 15; Pharma Companies Assess Changing Landscape

Nearly six years after negotiations started, the bilateral FTA between South Korea and the U.S. finally takes effect in March amid worries in Korea that it could ultimately harm generic-dependent local pharma companies.

Korea Ratifies Free Trade Agreement With U.S., Pleasing Pharma Industry

Patent linkage provisions among key benefits for the pharmaceutical industry.

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts